ABSTRACT:
Ayurveda is one of the oldest system of medicines having great emphasis on promotion of health and prevention of diseases. In the growing era of medicine, Nanotechnology holds promises due to its novel drug formulation routes, site-specific action, better solubility, improved efficacy and reduced side effects. Bhasma, literally meaning ash, is unique ayurvedic herbo-mineral-metallic compounds in the size of nanodimensions. Systematic nanomaterialistic investigations on bhasmas are recommended for gaining the complete and reliable composition-processing –structure- effectiveness picture of these drugs. This study aims to accumulate into on the ripen age old description notice and basic principles of ayurveda this would on ice the changed scholars, researchers and practitioners to worn out the challenge towards global acceptance and harmonization of such traditional nanomedicines called bhasmas.
Cite this article:
Pagar Swati A., Suryawanshi Hemant K.. Nanotechnology- Finding proofs for its ancient origin. Asian J. Res. Pharm. Sci. 2021; 11(1):65-70. doi: 10.5958/2231-5659.2021.00011.4
Cite(Electronic):
Pagar Swati A., Suryawanshi Hemant K.. Nanotechnology- Finding proofs for its ancient origin. Asian J. Res. Pharm. Sci. 2021; 11(1):65-70. doi: 10.5958/2231-5659.2021.00011.4 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-1-11
1.
Chauhan A et al. Ayurvedic research and
methodology: Present status and future strategies. Ayu. 2015; 36(4); 364–369.
2.
Dr. Satpute A. D.
Rasaratnasamucchaya- Sanskrit text with English translation, Delhi, Chaukhambha
Sanskrit Pratishthan: 2003; 10; 234.
3.
More B. Overview
of medicines-Its importance and impact. Int. J of Med Res. 2016; 1(1); 1-8.
4.
Kulkarni S.S, Bhasma and
nanomedicine Int. Res. J. Pharm.2013; 4(4); 10-16.
5.
Adabi M. et al. Biocompatibility and
nanostructured materials: applications in nanomedicine. Artif. Cells Nanomed.
Biotechnol. 2017; 45; 833–842.
6.
Albanese A, Tang P. S, Chan W. C.
The effect of nanoparticle size, shape, and surface chemistry on biological
systems. Annu. Rev. Biomed. Eng. 2012; 14; 1–16.
7.
Arora S, Rajwade J. M, Paknikar K.
M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl.
Pharmacol. 2012; 258; 151–165.
8.
Chandra S. Ayurvedic research, wellness and consumer rights. J. of Ayu and
Inte Med. 2016; 7; 6-10
9.
Sarkar P.K, Das S, Prajapati P.K. Ancient Concept of Metal Pharmacology
based on Ayurvedic Literature. Ancient Science of Life. 2010; 29(4);1-6.
10. Dr. Mistra S. N. Ayurvedic Rasshastra.Varanasi, 8th
edition Chaukhamba orientalia, 1998: 99.
11. Chaudhary A. Ayurvedic bhasma:
Nanomedicine of ancient India – Its global contemporary perspective. J Biomed
Nanotechnol. 2011; 7; 68‑9.
12. Dixit S. O et al. Pharmaceutical
fortification of Rasoushadhies for their better clinical utility. J of Ayu and
Inte Med Sci. 2017; 2 (1); 230-234.
13.
Acharya Siddinandan Mishra. Vagbhata- Rasaratna Samuchchaya. 1st edition.
Varanasi, Chaukhambha Orientalia, 2011; 697, 242.
14.
Prasadani commentary by Sri Hari Dutta Sastri. Rasa Tarangini - Pandit
Kashinath Sastri, NewDelhi; Moti Lal Banarasi Das Publishers; 11th
edition;2012;772, 22-24.
15.
Acharya Siddinandan Mishra. Vagbhata- Rasaratna Samuchchaya. 1st edition,
Chaukhambha Orientalia, Varanasi; 2011; 697, 242
16.
Sarkar P.K, Chaudhary A.K. Ayurvedic Bhasma: The most ancient application
of nanomedicine. J Sci Ind Res. 2010 ;69; 901-5
17.
Jain S. et al.
Pharmaceutical Processing and Analytical Study of Trivanga Bhasma. Ayushdhara.
2014; 1(1); 11- 16.
18.
Kapoor R.C. Some observations on the metal based preparations in the Indian
system of medicine. Ind J Tradit Kno. 2010; 9; 562‑75.
19.
Paul S, Chugh A. Assessing the role of Ayurvedic ‘bhasms’ as ethno‑nanomedicine in
the metal based nanomedicine patent regime. J Intellect Prop Rights. 2011; 16;
509‑15.
20.
Pal D, Sahu C.K, Haldar A. Bhasma: The ancient Indian nanomedicine. J Adv
Pharm Technol Res. 2014; 5;4‑12.
21.
Khedekar S.B,
Patgiri B, Prajapati P. K. Pharmaceutical Standardization of Swarna Bhasma
(Incinerated Gold) by Adopting Traditional Method. Annals of Ayu Med.2015;
4(3-4); 83-94.
22.
Brown C. L. et al.
The use of gold to treat experimentally induced arthritis in rat models:
Characterization of the gold in Swarna Bhasma: A microparticulate used in
traditional Indian medicine. Gold Bull. 2007; 40; 3.
23.
Singh K. et al.
Preparation and characterization of mercury based traditional drug-Rasasindoor.
Ind j of trad know. 2009;8;346-351.
24.
Singh S. K et al. Synthesis,
Characterization and Histopathological Study of a Lead-Based Indian Traditional
Drug: Naga Bhasma. Indian J Pharm Sci. 2010; 72(1); 24–30.
25.
Gupta G. K, Gupta Y.
K. Evidence for safety of Ayurvedic herbal, herbo-metallic and Bhasma
preparations on neurobehavioral activity and oxidative stress in rats. Ayu. 2012; 33(4);
569–575.
26.
Chaudhari S.
Y. et al. Acute and subchronic toxicity study of Tamra Bhasma
(incinerated copper) prepared with and without Amritikarana. J Ayurveda Integr
Med. 2016;
7(1); 23–29.
27.
jamadagni P.S. et
al. Toxicity Study of Swarna Bhasma, an Ayurvedic Medicine Containing Gold, in
Wistar Rats. Toxicol Int.2015.8;234-242.
28.
Kale B, Rajurkar
N. Synthesis and characterization of Vanga bhasma. J of Ayu and Inte
Med.2019;10;111-118.